Embold Therapeutics, Inc. — Form D
Embold Therapeutics, Inc. of REDWOOD CITY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-02-09. The offering totals $3.0M, of which $130K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-02-09
- Form: D
- Accession: 0002109643-26-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $130K
- Remaining: $2.9M
- Investors: 2
- Date of first sale: 2026-01-21
- Revenue range: Decline to Disclose
- SEC file number: 021-572899
Issuer
- Name: Embold Therapeutics, Inc.
- CIK: 0002109643
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 2682 EATON AVE, REDWOOD CITY, CA, 94062
- Phone: (650) 200-7297
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Gjalt W. Huisman | Director | Redwood City, CA |
| Gjalt W. Huisman | Executive Officer | Redwood City, CA |
| Gjalt W. Huisman | Related Person | Redwood City, CA |
Other filings by this issuer (2)
More